Browsing: Longevity

A new review highlights the promise of microglia replacement, a strategy that made the leap from mouse studies to the…

A new report released by Hevolution Foundation highlights that extending the number of years people live in good health is…

Scientists refine microglia replacement as a potential therapy for neurodegenerative disease – and progress is accelerating. Front-line innovation in neurodegenerative…

New collaboration aims to bring clarity, credibility and cohesion to the fast-growing longevity clinic ecosystem. Longevity.Technology and the International Institute…

Professor John Beard reflects on the societal shifts needed for humanity to capitalize on the healthspan dividend. This week’s release…

With programs targeting Alzheimer’s and Parkinson’s, company targets several major drivers of neurodegenerative disease. US biotech SciNeuro Pharmaceuticals has secured…

New open-science consortium seeks to quantify joy as a biological input with real and measurable healthspan relevance. Frontier Towers, San…

Fountain Life’s Executive Health Membership Program shows how AI-guided prevention can unlock major savings and extend workforce healthspan. Fountain Life…

FDA greenlights early-stage trial of VectorY’s first-in-class therapy targeting the core biology driving most ALS cases. Netherlands-based biotech VectorY Therapeutics…

New MRI study shows hidden belly fat and muscle mass influence brain aging and may affect Alzheimer’s risk. Want to…